Our Stocks to Watch today include EcoBlu Products Inc. (OTCBB: ECOB), Gen2Media Corp. (OTCBB: GTWO), Optical Systems Inc. (OTC: OPSY), Sinobiopharma Inc. (OTCBB: SNBP), Wind Works Power Corp. (OTCBB: WWPW), Netlist Inc. (Nasdaq: NLST), Viking Systems Inc. (OTCBB: VKNG), Kiwa Bio-Tech Products Group Corp. (OTCBB: KWBT), Montavo Inc. (OTCBB: MTVO), Accredited Business Consolidators/Italian Oven Corp. (OTC: IOVE) and Health Discovery Corp. (OTCBB: HDVY).
Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover’s Digest Newsletter and Email Stock Watch Alerts.
ECOBLU PRODUCTS INCORPORATED (OTCBB: ECOB)
"Up 17.65% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/ECOB.php
Company Profile: http://www.otcpicks.com/ecoblu-products.htm
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company's revolutionary diagnostic systems, which are based on advanced magnetics, test for any viral or bacterial disease using any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies.
ECOB News:
November 19 - EcoBlu Signs Exclusive Licensing Agreement With Hartindo Fire Protection Supplier Megola
Fire Inhibitor Protects Engineered Wood; Adds to EcoBlu's Mold, Rot-Decay and Termite Shield
EcoBlu Products, Inc. (OTCBB: ECOB), provider of eco-friendly, protected wood products, has signed an exclusive licensing agreement with fire protection supplier Megola, (OTC: MGOA), adding to the company's proprietary BLUWOOD™ technology which protects wood from the harmful effects of mold, rot-decay and termites. The exclusive partnership enables EcoBlu to protect both dimensional lumber and engineered wood against another devastating threat — fire.
As a part of the agreement, EcoBlu has acquired the exclusive rights to Megola's Hartindo AF21 Fire Inhibitor in
"In addition to protecting wood from mold, termites, wood-rot and now fire, this agreement provides EcoBlu with a comprehensive solution able to address the long-standing problem of the increased flammability of engineered wood products," said Steve Conboy, President and CEO of EcoBlu Products, Inc.
The increased flammability of Engineered Wood Products versus natural dimensional wood products has caused concern among Industry leaders, fire protection advocates and project designers. Demand for engineered wood products continues to grow due to their strength, cost effectiveness and the lack of mature dimensional lumber. Protecting engineered wood from fire will mitigate this threat to safety and support further growth for engineered products.
"We sought to partner with EcoBlu because they have the potential to be the leader in this important building products category and have the expertise and capacity to grow swiftly," said Joel Gardner, president and CEO of Megola, Inc.
Megola, recognized as an industry leader in fire protection, will supply EcoBlu with its proprietary, non-toxic, environmentally friendly solution, utilizing its blending facilities in the
ABOUT MEGOLA, INC.
Megola Inc. is a Nevada Corporation based in Point Edward,
GEN2MEDIA CORPORATION (OTCBB: GTWO)
"Up 25.00% in morning trading"
Detailed Quote: www.otcpicks.com/quotes/GTWO.php
Company Profile: http://www.otcpicks.com/Newsletter/GTWO_102809.html
Gen2Media is a fully integrated technology, production and marketing company whose proprietary and patent-pending technology has earned the trust of a growing, globally diversified customer base, comprised of leading media companies, corporations, chart-topping artists, entertainment companies, advertising agencies and national brands such as The Black Eyed Peas, Mary J. Blige, Britney Spears, Justin Timberlake, Microsoft Xbox LIVE, Coca-Cola Company, Toyota, Clear Channel, and others.
GTWO News:
November 18 - A New Audio Interview with Mark Argenti, CEO of Gen2Media Corp., is Now at SmallCapVoice.com
SmallCapVoice.com, Inc. announced that a new audio interview with Gen2Media Corp. (OTCBB: GTWO) is now available. The interview can be heard at http://smallcapvoice.com/blog/11-17-09-audio-interview-gen2media-corporation-otcbb-gtwo/.
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and investor fact sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets.
OPTICAL SYSTEMS INCORPORATED (OTC: OPSY)
Detailed Quote: http://www.otcpicks.com/quotes/OPSY.php
Company Profile: http://www.otcpicks.com/optical-systems/optical-systems.htm
Optical Systems, Inc., through its operating subsidiary, Automotive Software Designers, Inc., develops technology and services for the automotive retail industry designed to maximize productivity and increase profits at auto dealerships. ASDI's flagship technology solution, Save-a-Deal, is a turnkey customer relationship management (CRM) tool for auto dealerships. Our business development center (BDC) provides a variety of services designed to help auto dealerships drive traffic to their showroom or Web site, retain customers and generate new streams of revenue.
OPSY News:
November 18 - Optical Systems, Inc. Signs Marketing Agreement to Target 1,700 East Coast Dealerships With Its Flagship CRM Software, Save-a-Deal 2010
Potential annual revenue from Save-a-Deal could exceed $50 million
Automotive Software Designers, Inc., a leading provider of software and services for the automotive retail industry and a wholly owned subsidiary of Optical Systems, Inc. (OTC: OPSY) announced that it has selected DealerDX, LLC to exclusively market the latest version of the Company's flagship customer relationship management (CRM) software, Save-a-Deal, to automobile and recreational vehicle dealerships across Maryland, Pennsylvania and Virginia.
"There are more than 1,700 dealerships in the Northeast, "said B.J. Grisaffi, Chairman and Chief Executive Officer of Optical Systems, Inc. "Save-a-Deal has the potential to generate more than $50 million in annual revenue if we are able to sign 50 percent of those dealerships. This agreement could be a game changer for our Company and our shareholders."
DealerDX, LLC is a private consulting firm, and a member of the National Association of Minority Automobile Dealers (NAMAD). Teresa Beasley who recently joined forces with DealerDX after a 20-year career with Reynolds and Reynolds said: "Save-a-Deal 2010 is key to driving dealership productivity, quality, and profit improvements. Save-a-Deal is designed for dealers by dealers."
Save-a-Deal is a comprehensive, fully-integrated front office software solution specifically designed to increase auto dealerships' profitability. When properly used, this scalable CRM system is guaranteed to increase unit sales and profit-per-vehicle, while lowering costs through enhanced efficiency. Save-a-Deal 2010 is a more streamlined, cost-effective CRM solution than its predecessor with added capabilities in remote personnel management, customer service, training, and security.
"Save-a-Deal 2010 is an amazing product that has the potential to revolutionize daily operations at automobile, RV, motorcycle, and boat dealerships," said Lee Putney, President and Founder of DealerDX, LLC. "We are excited about expanding our role with the company, and target new dealerships in key markets across the
SINOBIOPHARMA INCORPORATED (OTCBB: SNBP)
Detailed Quote: http://www.otcpicks.com/quotes/SNBP.php
Company Profile: http://www.otcpicks.com/sinobiopharma/sinobiopharma.htm
Sinobiopharma, Inc. is a fully integrated and highly innovative specialty biopharmaceutical company engaged in the research and development, manufacture and marketing of biopharmaceutical products in
SNBP News:
November 19 - Zacks Equity Research Initiates Coverage on Sinobiopharma
Zacks Equity Research has initiated investment research coverage on Sinobiopharma, Inc. (OTCBB: SNBP) with an Outperform and six month target price of $0.80.
The company holds five patents in Chiral Pharmaceutical Ingredient Synthesis and Purification, and Molecular Packaging Formulation (see proprietary technology section) and has the longer-term ability to expand both the breadth of its product line and market share through R&D partnerships with
Trading Overview for Sinobiopharma Inc. Issued by StockPreacher.com
StockPreacher.com announces an investment report featuring biotechnology company Sinobiopharma Inc. (OTCBB: SNBP). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.
The investment report on Sinobiopharma Inc. (OTCBB: SNBP) should be of particular interest to other biotechnology companies: Sunesis Pharmaceuticals Inc. (Nasdaq: SNSS), Prestige Brands Holdings Inc. (NYSE: PBH), Synta Pharmaceuticals Corp. (Nasdaq: SNTA) and GlaxoSmithKline plc (NYSE: GSK).
The full report is available at www.stockpreacher.com/n/SNBP
Sinobiopharma Inc. (SNBP) is an emerging, fully integrated and highly innovative biotechnology company engaged in the research and development, manufacture and marketing of biopharmaceutical products in
In the report, the analyst notes:
"SNBP's key product is a patented version of Cisatracurium besylate, a pre-surgical skeletal muscle relaxant marketed as Kutai in
"SNBP conducts research and development through Nanjing Su Ji Biotech Research Development Center and in cooperation with the Medicinal Chemistry Research Institute,
WIND WORKS POWER CORPORATION (OTCBB: WWPW)
"Up 6.06% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/WWPW.php
Company Profile: http://www.otcpicks.com/wind-works-power.htm
Wind Works' mission is to become a leading developer of wind energy projects in North America and
WWPW News:
November 19 - Optical Systems, Inc. Launches New Version of Its Flagship CRM Product, Save-a-Deal
Wind Works Power Corp. (OTCBB: WWPW) (Frankfurt: R5E1) (WKN: AOKE72) announced that it is submitting an application for its 10 megawatt (MW) Clean Breeze wind energy project for a power contract under the new Feed-in Tariff program as part of the Ontario Power Authority initial launch period.
"We are excited to be submitting our first application for a power contract under the new Feed-in Tariff program in
The Feed-in Tariff (FIT) contract program is part of the new Green Energy Act in
Clean Breeze is 10MW project located in
ABOUT ZERO EMISSION PEOPLE
The vision of Zero Emission People is to provide the opportunity for anyone to invest early in the development of renewable wind energy projects. As an example, as little as a $10,000 investment in a wind park blows away a person's carbon footprint. We believe in making sound, environmentally conscious investments that are good for all shareholders, people and our planet.
NETLIST INCORPORATED (NASDAQ: NLST)
"Up 16.98% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/NLST.php
Netlist, Inc. designs and manufactures high-performance, logic-based memory subsystems for the server and high-performance computing and communications markets. The Company's memory subsystems are developed for applications in which high-speed, high-capacity memory, functionality, small form factor, and heat dissipation are key requirements. These applications include tower-servers, rack-mounted servers, blade servers, high-performance computing clusters, engineering workstations, and telecommunication equipment. Netlist was founded in 2000 and is headquartered in
NLST News:
November 16 - Beacon Equity Issues Technical Trading Overview for Netlist Inc.
BeaconEquity.com announces an investment report featuring Netlist Inc. (Nasdaq: NLST). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
The investment report on Netlist Inc. (Nasdaq: NLST) should be of particular interest to other semiconductor companies: SMART Modular Technologies (WWH) Inc. (Nasdaq: SMOD), STEC Inc. (Nasdaq: STEC) and
It is available at www.beaconequity.com/i/NLST.
Netlist Inc. (NLST) designs, manufactures and sells memory subsystems primarily for the server, high-performance computing and communications markets. The Company's memory subsystems consist of dynamic random access memory integrated circuits (DRAM ICs), NAND flash memory (NAND) and other components assembled on a printed circuit board (PCB).
"NLST recently launched HyperCloud™, the world's first 16GB, 2 virtual rank (vRank) memory module for servers. A double-data-rate three, registered dual in-line memory module (DDR3 RDIMM), HyperCloud maximizes server utilization to improve datacenter application performance. HyperCloud allows 384 Gigabytes (GB) of dynamic random access memory (DRAM) to be populated in a single dual socket server, reaching unprecedented levels of server performance.
"NLST announced last month that it has commenced federal litigation against Westlake Village, CA-based Inphi Corporation, a high-speed analog semiconductor company, alleging that Inphi's iMB line of isolation memory buffer integrated circuits infringe Netlist's U.S. Patent No. 7,532,537. In its Complaint filed September 22, 2009 in U.S. Central District of California, Western Division, Netlist is seeking unspecified monetary damages and requests immediate and permanent action barring Inphi from making and selling infringing product..."
To read the entire report, visit www.beaconequity.com/i/NLST.
VIKING SYSTEMS INCORPORATED (OTCBB: VKNG)
"Up 5.13% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/VKNG.php
Viking Systems, Inc. (OTCBB: VKNG) is a leading worldwide developer, manufacturer and marketer of visualization solutions for complex minimally invasive surgery. The Company partners with medical device companies and healthcare facilities to provide surgeons with proprietary visualization systems enabling minimally invasive surgical procedures, which reduce patient trauma and recovery time.
VKNG News:
November 18 - Trading Review for Viking Systems Inc. Issued by Beacon Equity
BeaconEquity.com announces an investment report featuring medical device maker Viking Systems Inc. (OTCBB: VKNG). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
The investment report on Viking Systems Inc. (OTCBB: VKNG) should be of particular interest to medical device companies Boston Scientific Corp. (NYSE: BSX), Medtronics Inc. (NYSE: MDT) and Saint Jude Medical Inc. (NYSE: STJ).
It is available at www.beaconequity.com/i/VKNG.
KIWA BIO-TECH PRODUCTS GROUP CORPORATION (OTCBB: KWBT)
"Up 2.86% in morning trading"
Detailed Quote: www.otcpicks.com/quotes/KWBT.php
The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes.
KWBT News:
November 12 - Kiwa Bio-Tech Reports Third Quarter Results
Kiwa Bio-Tech Products Group Corporation (OTCBB: KWBT) announced results for the third quarter and for the first nine months of 2009.
Revenues for the third quarter of 2009 were $1,374,561 a decrease of 40.9% from revenues of $2,327,315 in the third quarter of 2008. This decrease was in part due to deliberate reduction in sales of low margin bio-fertilizer and bio-feed products. In addition, the Company's efforts in boosting sales revenue were partially offset by requests to customers of cash payment at the time of purchase.
During the three months ended September 30, 2009, cost of sales was $1,351,838, representing a decrease of $919,934 or 40.5%, compared with $2,271,772 for the same period of 2008. The sharp decrease of cost of sales was mainly attributable to reduction of revenue.
Net loss, attributable to Kiwa shareholders, for the third quarter of 2009 was $516,933 compared to a net loss, attributable to Kiwa shareholders, of $567,770 in the same period of 2008.
Revenues for the first nine months of 2009 were $2,864,253 compared to $7,539,083 in the first nine months of 2008. During the nine months ended September 30, 2009, net loss attributable to Kiwa's shareholders was $1,962,356, an increase of $77,370 or 4.1%, compared with $1,884,986 for the same period of 2008.
Please refer to documents filed with the Securities and Exchange Commission for additional information on the results for the third quarter and first nine months of 2009.
Mr. Wei Li, Chairman and CEO of Kiwa, noted, "We remain focused on strengthening manufacturing and marketing resources to develop our various business segments and product lines. The Company also continues to seek to secure financing that will provide flexibility in building our business and improve the balance sheet."
MONTAVO INCORPORATED (OTCBB: MTVO)
"Up 70.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MTVO.php
Montavo, Inc.'s mMAP is a mobile marketing platform that integrates client side mobile device software with a mobile advertising network solution and ad distribution ecosystem. Montavo offers its solution to consumer focused advertisers (manufacturers and retailers from national brands to SMBs), wireless carriers, mobile handset manufacturers and mobile OS providers, personal navigation device (PND) manufacturers, automotive manufacturers, and other tier-one suppliers as either a white-labeled mobile application or as the Montavo branded mDealFinder™. Montavo's proprietary, patent-pending mobile advertising platform has been designed from the ground up to deliver the most relevant, location-based deals on products or services to consumers while providing rich real-time data and analytics on mobile ad campaign performance and ROI to advertisers that primarily sell their products in a brick and mortar setting.
MTVO News:
November 19 - Montavo Announces Engineering Development for the iPhone and iPod Touch to Coincide With the Release of Rev. 3.0
Montavo, Inc. (OTCBB: MTVO) announced that the Company has prioritized engineering development efforts for mDealFinder™, the company's flagship mobile application, as well as the Montavo Mobile Advertising Platform (mMAP) for the Apple iPhone and Apple iPod Touch so the platform will be supported with the release of Rev. 3.0 planned for Q1 2010.
With over 100 million iPhone and iPod Touch downloaded applications each month via the App Store, the Apple platform has clearly set the standard for mobile applications.
Montavo recently announced an initiative to upgrade the overall user interface (UI) and user experience (UX) of both the mDealFinder™ application as well as mMAP suite of online tools for advertisers. These enhancements will also be incorporated into the iPhone and iPod Touch mDealFinder™ application which are focused on providing seamless, intuitive user interactions.
"We're very excited about our recent focus and prioritization of the development for the iPhone and iPod Touch mDealFinder™ application," said Brook Lang, CEO of Montavo. "With the rapidly growing footprint of both devices, we're looking forward to providing consumers with an innovative, intuitive, free application that will help them save significant dollars on everything from groceries to dress shoes to flat screen TVs in real-world store locations. Our ability to deliver mobile coupons, product information & launches, discounts, and savings opportunities to consumers by marrying their location with retailers that are offering the best deals on products or services they are looking to buy is unparalleled."
ACCREDITED BUSINESS CONSOLIDATORS CORP. (OTC: IOVE)
"Up 5.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/IOVE.php
Accredited Business Consolidators Corp., formerly known as the Italian Oven, is a diversified holding corporation. Visit www.accreditedbiz.com (under construction) for information on its affiliated companies. The total number of common shares outstanding is 436,399,500. 328,018,200 shares are in the public float and on hand with CEDE & Co., 70,546,600 shares are restricted in certificate form, and 37,834,700 shares are unrestricted but in certificate form. There will be no increase in shares until at least April 2010.
IOVE News:
November 19 - Accredited Suppliers Corp. Begins Operations in
Accredited Business Consolidators Corp. (trading as Italian Oven) (OTC: IOVE) announced that its subsidiary Accredited Suppliers Corp. began revenue producing operations. ASC's business involves wholesale distribution of automotive parts and printing supplies to businesses in
After negotiating and coming to supplier agreements with several retailers of auto parts in
By beginning operations before the end of the year, ASC can file a registration statement with the Securities and Exchange Commission in early January so that it may divest itself of the company by spinning it off, 1:1, to avoid commingling operations with IOVE's core businesses. This is necessary because most of ASC's business transactions will be in foreign currencies and the entity will be managed by officers located in Central America that are not officers of IOVE. Management for the subsidiary will be formally appointed within two weeks and IOVE will only control a director's position.
Accredited Business Consolidators Corp., f/k/a the Italian Oven, is a diversified holding corporation. The total number of common shares outstanding is 436,399,500. 328,018,200 shares are in the public float, 70,546,600 shares are restricted in certificate form, and 37,834,700 shares are unrestricted but in certificate form. There will be no increase in common shares until at least April 2010.
HEALTH DISCOVERY CORPORATION (OTCBB: HDVY)
"Up 4.88% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/HDVY.php
Savannah-based Health Discovery Corporation is uniquely positioned in the field of pattern recognition technology. Through the application of its patent protected technology, HDC is a leader in SVM-based molecular diagnostic and prognostic test development in genomics and proteomics, as well as, digital image analysis in pathology and radiology. The Company's SVM and FGM pattern recognition tools have significant application potential in other sizable commercial markets such as oil exploration, financial markets, Internet search and spam, homeland security, and other areas where analysis of large volumes of complex data is required.
HDVY News:
November 4 - Health Discovery Corporation Offers an Intra-Quarterly Update, Commentary on the Value of Prostate Cancer Screening and Invites the American Cancer Society to Act Immediately
Due to the recent downward pressure on the price of Health Discovery Corporation’s common stock (OTCBB: HDVY) after breaking through multiple 52-week highs in a few short weeks as it did in the past month, the Company has received numerous investor inquiries. Given these inquiries and in order to make Company information available on a uniform basis, the Company would like to provide an intra-quarterly update on its activities, to and including, but not limited to, the following since its most recent quarterly filing:
* The Company’s private placement Series B fund raising is going extremely well and the Company expects to close this round of financing in the next few weeks. These Series B shares are not common shares and are not registered with the Securities and Exchange Commission. We are pleased to announce that many of the participants in this Series B funding round are current shareholders of the Company.
* The Company continues to make great progress on its urine-based prostate cancer test.
As previously announced, HDC recently entered into royalty-bearing licenses for its new urine-based prostate cancer test with Quest Diagnostics Incorporated (NYSE: DGX) and Abbott Laboratories (NYSE: ABT) for development and commercialization. The Company also entered into royalty-bearing licenses for its tissue biopsy-based prostate cancer test with Abbott Laboratories (NYSE: ABT) and Clarient Inc. (Nasdaq: CLRT) for development and commercialization.
* The Company’s minority-owned subsidiary, Smart Personalized Medicine, LLC, has recently entered into a licensing agreement with a world-renowned international cancer center to develop a breast cancer prognostic test and, with the Company, are currently in discussions with a national clinical laboratory for development and commercialization of the test.
* The Company is finalizing the image processing development on its PAP Smear interpretation test. The Company entered into a development and commercialization agreement with DCL Laboratories for this test as well as tests for ovarian and endometrial cancer.
* Discussions are underway with an international diagnostics company regarding the development and commercialization of the Company’s colon cancer molecular diagnostic test.
* Since the recent press release on the status of the Company’s IP portfolio on October 19, 2009, the United States Patent and Trademark Office has issued additional Notices of Allowance on two of HDC’s patent applications covering the use of SVMs for analysis of spectral data. Spectral data are generated by instruments including mass spectrometers, which are widely used for detection of chemical properties of materials that can be analyzed based on their atomic or molecular weights, optical detectors, such as infrared telescopes and laser analyzers, audio signal analyzers, and medical testing systems, such as EEG and ECG analysis. Both patent applications cover the direct analysis of spectral data using SVMs, which represents a significant improvement over earlier methods that required identification and extraction of individual peaks in the spectra, which was frequently a manual operation, before any analysis could occur.
“As a Company, we are focused on creating shareholder value and expect that from time to time shareholders will take some profits from their investment, especially when the company breaks through multiple 52-week highs in a few short weeks as we did in the past month,” Dr. Barnhill said. “Additionally, we were proud to be recently listed by the Wall Street Journal Market Watch as a “Best Performing Stock” in the Biotechnology sector.
“Over the past several months, the Company has taken prudent, definitive steps to strengthen its staffing, to bolster its investor relations/public relations capacity by hiring a
“I am very excited by our progress and feel that there has never been a more promising time in the Company’s history than now,” said Dr. Barnhill.
Prostate Cancer Screening Remains Vitally Important
There appears to be considerable confusion in the media regarding the American Cancer Society’s position on the value of universal prostate cancer screening. The critical issue regarding the American Cancer Society’s position on prostate cancer screening is not that screening, per se, is unwarranted but that the currently available PSA diagnostic test is inadequate for justifying mass screening for prostate cancer, and that a new, more accurate test is desperately needed. In other words, it is the test, not the testing, that is inadequate, wasteful, and in some cases, harmful, and given the availability of the “right” test, it would be unwise to abandon prostate cancer screening or even seriously consider doing so.
HDC receives, licensing and milestones fees as well as royalty payments on a per test basis upon the sale of patient tests, including HDC’s prostate cancer tests. HDC’s initial target market for prostate cancer is significant. For example, in the
According to Dr. Barnhill, “The future for cancer screening is indeed bright.” In fact, it would be impossible to accomplish the nation’s best visions for healthcare-reform without vastly increasing the numbers of patients being screened and the frequency of their early-detection screenings—as well as increasing the use of companion diagnostic tests to screen for those patients who are likely to respond favorably to an expensive or dangerous therapy, such as chemotherapy.
HDVY Invites the American Cancer Society to Act Immediately
Given the promising future of molecular diagnostic testing, and the increased accuracy of these tests, Health Discovery Corporation asks that the American Cancer Society immediately and strongly reassert its position that, at least, in the case of prostate cancer screening, the availability of a new and vastly superior screening diagnostic tool could be of immense public health benefit.
If we focus on the science, as well as the economics, because, as it turns out both are in alignment here, we will jointly get to the right place after all, a place where the benefits of prostate cancer screening using a new, very powerful test far outweigh the risks and other costs.
OTCPicks.com is located at
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov/ and FINRA at http://www.finra.org/.
Disclosure: OTCPicks has been compensated five thousand dollars from a third party for ECOB advertising and promotional services. OTCPicks.com has been compensated two thousand dollars by a third party (Blue Wave Advisors) for a one week GTWO advertising and promotional program. OTCPicks.com has been compensated ten thousand dollars by a third party (Emerging Market Consultants) for GTWO advertising and promotional services. OTCPicks.com has been compensated two hundred seventy five thousand free trading shares by a third party for OPSY advertising and promotional services. OTCPicks.com has been compensated five thousand dollars from a non-controlling third party for SNBP advertising and promotional services. Previously OTCPicks has been compensated three thousand dollars by a third party (WFWS Consulting) for SNBP advertising and promotional services. OTCPicks.com has been compensated two thousand five hundred dollars from a non-controlling third party (BlueWave Advisors) for WWPW advertising and promotional services. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. OTCPicks.com is a website partially owned by BlueWave Advisors, LLC, a financial public relations firm. BlueWave Advisors, LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
